United States Dialysis Market Size & Forecast 2025–2033

The United States Dialysis Market is on a strong upward trajectory, expanding from US$ 1.35 billion in 2024 to US$ 1.96 billion by 2033, according to Renub Research. This represents a robust CAGR of 4.25% during 2025–2033, driven by the increasing prevalence of kidney disease, rapid technological improvements in dialysis equipment, and a growing aging population requiring long-term renal care.

Dialysis plays a critical role in sustaining life for patients with kidney failure. As kidney diseases continue to escalate across the country—and transplant organs remain in short supply—the demand for dialysis services, equipment, consumables, and home-based solutions continues to grow at an unprecedented pace.

Understanding the United States Dialysis Market

Dialysis acts as a life-support therapy when kidneys can no longer filter waste and excess fluid from the blood. In the U.S., where nearly half a million people depend on dialysis, the therapy is often the only viable long-term option for patients with End-Stage Renal Disease (ESRD).

There are two major types:

1. Hemodialysis (HD)

Blood is filtered using an external machine, typically in a dialysis center three times a week.

2. Peritoneal Dialysis (PD)

A home-based therapy using the abdominal lining as a natural filter, allowing greater flexibility and independence.

Both forms are essential components of the U.S. renal care ecosystem, but home dialysis is emerging as a major growth area due to patient convenience, improving technologies, and strong government support.

Market Outlook: Why Dialysis Demand Is Surging

Rising Burden of Chronic Kidney Disease (CKD) and ESRD

The single largest driver of the dialysis market is the rising number of CKD and ESRD patients.

Over 35.5 million U.S. adults—around 1 in 7 Americans—are estimated to have CKD.

Many eventually progress to ESRD, requiring lifelong dialysis or kidney transplantation.

Transplants remain limited due to chronic organ shortages, making dialysis the default therapy for survival.

Diabetes, hypertension, obesity, and aging—key risk factors for CKD—continue to rise across the population, ensuring sustained demand for dialysis services and equipment.

Technological Breakthroughs Improving Efficiency and Comfort

Innovation is transforming dialysis delivery and patient outcomes.

Key advancements include:

High-efficiency hemodialysis machines with real-time monitoring and personalized treatment parameters

Next-generation peritoneal dialysis cyclers offering automated overnight treatment

Wearable and portable dialysis systems (in development) for increased mobility

Telehealth integration enabling remote patient monitoring

Biocompatible dialysis solutions minimizing complications and improving safety

A notable recent innovation comes from UNC-Chapel Hill, where researchers are developing a cutting-edge membrane technology capable of miniaturizing dialysis devices, potentially paving the way for compact, wearable systems.

Home Dialysis Momentum Accelerates

Home dialysis is one of the fastest-growing segments of the U.S. market.

Government policies and reimbursement reforms have significantly boosted adoption:

Medicare Part B covers 80% of home dialysis costs—including training, equipment, and supplies.

CMS programs such as "Advancing American Kidney Health" encourage home treatment to improve quality of life and reduce system-wide healthcare costs.

Patients benefit from:

More flexible treatment schedules

Fewer clinic visits

Greater independence

Improved comfort and convenience

As technology becomes easier to use and more providers expand training programs, home dialysis adoption is expected to rise sharply through 2033.

Challenges Facing the U.S. Dialysis Market

High Treatment Costs and Economic Pressures

Dialysis remains one of the most expensive long-term medical therapies.

Patients receive treatment multiple times weekly.

Machines, consumables, and staffing add substantial costs.

Even with Medicare support, many patients face significant out-of-pocket expenses.

Providers often struggle with reimbursement shortfalls and rising operating expenses.

These economic factors limit market expansion in medically underserved regions.

Workforce Shortages and Overcapacity

The U.S. healthcare workforce is facing persistent shortages, and dialysis is no exception.

Not enough nephrologists, specialized nurses, and technicians to meet rising demand

Staff burnout and turnover strain existing facilities

Rural areas face limited access to trained providers

Shortages hinder expansion of home dialysis due to training gaps

These issues pose serious concerns for maintaining high-quality care nationwide.

Key Market Segments

By Type

Hemodialysis

Peritoneal Dialysis

By Product & Services

Services (largest revenue generator)

Equipment

Consumables

Drugs

By End User

In-Center Dialysis

Home Dialysis

United States Peritoneal Dialysis Market

The U.S. peritoneal dialysis (PD) market is expanding rapidly, supported by:

Increased patient preference for home-based treatments

New biocompatible solutions that reduce infection risks

Automating technologies such as nighttime cyclers

Favorable reimbursement from Medicare and private insurers

However, challenges such as peritonitis risk, need for patient training, and caregiver support remain key areas of concern.

United States Dialysis Services Market

Dialysis services form the backbone of the U.S. market, dominated by large players like DaVita and Fresenius Medical Care.

Main growth drivers include:

Increasing ESRD prevalence

Expanding home dialysis training programs

Telehealth-based remote monitoring

Patient education initiatives

Despite financial and staffing challenges, service providers continue to invest heavily in value-based care programs and digital health solutions.

United States Dialysis Equipment Market

Equipment demand remains consistently strong, propelled by:

State-of-the-art hemodialysis machines

Portable devices enabling at-home treatment

Advanced peritoneal dialysis cyclers

High recurring demand for consumables (dialyzers, catheters, tubing)

Companies are focusing on R&D to improve patient comfort, reduce complications, and increase automation. Hospitals and clinics continue upgrading older systems, contributing to steady sales growth.

United States Home Dialysis Market

Home dialysis is one of the most promising segments:

Government incentives driving adoption

Portable and user-friendly devices on the rise

Patients choosing independence and flexibility

Improved quality of life compared to in-center care

Although training, safety protocols, and remote supervision are essential, the shift toward home-based therapies is expected to accelerate through 2033.

State-Level Insights

California Dialysis Market

California represents one of the largest dialysis markets in the country due to:

High population

Elevated diabetes prevalence

Modern healthcare infrastructure

Strong adoption of home dialysis and new technologies

However, challenges include high operational costs and gaps in rural access.

New York Dialysis Market

New York continues to see rising demand driven by:

High CKD incidence

Concentrated urban healthcare systems

Growing acceptance of home dialysis

Strong Medicare and Medicaid support

Staffing shortages and high operating costs remain hurdles for providers.

New Jersey Dialysis Market

Growth in New Jersey is fueled by:

Aging population

High diabetes and hypertension rates

Proximity to major medical hubs

Medicare and private insurance coverage

Staff shortages and rising healthcare costs remain key obstacles, but the state continues to develop its home dialysis ecosystem.

Top States in the U.S. Dialysis Market

California

Texas

New York

Florida

Illinois

Pennsylvania

Ohio

Georgia

New Jersey

Washington

North Carolina

Massachusetts

Virginia

Michigan

Maryland

Colorado

Tennessee

Indiana

Arizona

Minnesota

Wisconsin

Missouri

Connecticut

South Carolina

Oregon

Louisiana

Alabama

Kentucky

Rest of United States

Leading Companies Covered (5 Viewpoints for Each)

Asahi Kasei Corporation

B. Braun Melsungen AG

Baxter International Inc.

Becton Dickinson and Company

DaVita Inc.

Fresenius Medical Care AG & Co. KGaA

JMS Co. Ltd.

Medtronic Plc

Each company analysis includes:

Overview • Key Person • Recent Developments • SWOT Analysis • Revenue Analysis

Final Thoughts

The United States Dialysis Market is poised for substantial growth through 2033 as the burden of kidney disease escalates and technological advancements reshape treatment delivery. Home dialysis—boosted by policy support, telehealth integration, and patient empowerment—will be the driving force of market expansion in the coming decade. However, challenges such as cost management, workforce shortages, and disparities in rural access must be addressed to ensure equitable and sustainable care.

With Renub Research projecting the market to reach US$ 1.96 billion by 2033, the U.S. dialysis ecosystem stands at a transformative point, ready to deliver more patient-centered, technologically advanced, and accessible renal care across the nation.